A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (vol 138, pg 237, 2019): A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

Sven J. van der Lee; Erik van den Akker; Najada Stringa; Marc Hulsman; Niccolo Tesi; P. Alexopoulos; G. Rossi; J. van der Zee; Marcel J.T. Reinders; null More Authors

doi:10.1007/s00401-019-02107-8

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (vol 138, pg 237, 2019): A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

Sven J. van der Lee^*, Erik van den Akker, Najada Stringa, Marc Hulsman, Niccolo Tesi, P. Alexopoulos, G. Rossi, J. van der Zee, Marcel J.T. Reinders, More Authors

^*Corresponding author for this work

Pattern Recognition and Bioinformatics

Research output: Contribution to journal › Comment/Letter to the editor › Scientific › peer-review

Abstract

The IPDGC (The International Parkinson Disease Genomics Consortium) and EADB (Alzheimer Disease European DNA biobank) are listed correctly as an author to the article, however, they were incorrectly listed more than once.

Original language	English
Pages (from-to)	959-962
Number of pages	4
Journal	Acta Neuropathologica
Volume	139
Issue number	5
DOIs	https://doi.org/10.1007/s00401-019-02107-8
Publication status	Published - 2020

Access to Document

10.1007/s00401-019-02107-8

Fingerprint

Dive into the research topics of 'A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (vol 138, pg 237, 2019): A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)'. Together they form a unique fingerprint.

Cite this

van der Lee, S. J., van den Akker, E., Stringa, N., Hulsman, M., Tesi, N., Alexopoulos, P., Rossi, G., van der Zee, J., Reinders, M. J. T., & More Authors (2020). A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (vol 138, pg 237, 2019): A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8). Acta Neuropathologica, 139(5), 959-962. https://doi.org/10.1007/s00401-019-02107-8

van der Lee, Sven J. ; van den Akker, Erik ; Stringa, Najada et al. / A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (vol 138, pg 237, 2019) : A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8). In: Acta Neuropathologica. 2020 ; Vol. 139, No. 5. pp. 959-962.

@article{15cc2f6e87de421f9bd855b6424dea89,

title = "A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (vol 138, pg 237, 2019): A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer{\textquoteright}s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)",

abstract = "The IPDGC (The International Parkinson Disease Genomics Consortium) and EADB (Alzheimer Disease European DNA biobank) are listed correctly as an author to the article, however, they were incorrectly listed more than once.",

author = "{van der Lee}, {Sven J.} and {van den Akker}, Erik and Najada Stringa and Marc Hulsman and Niccolo Tesi and P. Alexopoulos and G. Rossi and {van der Zee}, J. and Reinders, {Marcel J.T.} and {More Authors}",

year = "2020",

doi = "10.1007/s00401-019-02107-8",

language = "English",

volume = "139",

pages = "959--962",

journal = "Acta Neuropathologica",

issn = "0001-6322",

publisher = "Springer",

number = "5",

}

van der Lee, SJ, van den Akker, E, Stringa, N, Hulsman, M , Tesi, N, Alexopoulos, P, Rossi, G, van der Zee, J, Reinders, MJT & More Authors 2020, 'A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (vol 138, pg 237, 2019): A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)', Acta Neuropathologica, vol. 139, no. 5, pp. 959-962. https://doi.org/10.1007/s00401-019-02107-8

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (vol 138, pg 237, 2019): A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8). / van der Lee, Sven J.; van den Akker, Erik; Stringa, Najada et al.
In: Acta Neuropathologica, Vol. 139, No. 5, 2020, p. 959-962.

Research output: Contribution to journal › Comment/Letter to the editor › Scientific › peer-review

TY - JOUR

T1 - A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (vol 138, pg 237, 2019)

T2 - A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

AU - van der Lee, Sven J.

AU - van den Akker, Erik

AU - Stringa, Najada

AU - Hulsman, Marc

AU - Tesi, Niccolo

AU - Alexopoulos, P.

AU - Rossi, G.

AU - van der Zee, J.

AU - Reinders, Marcel J.T.

AU - More Authors, null

PY - 2020

Y1 - 2020

N2 - The IPDGC (The International Parkinson Disease Genomics Consortium) and EADB (Alzheimer Disease European DNA biobank) are listed correctly as an author to the article, however, they were incorrectly listed more than once.

AB - The IPDGC (The International Parkinson Disease Genomics Consortium) and EADB (Alzheimer Disease European DNA biobank) are listed correctly as an author to the article, however, they were incorrectly listed more than once.

UR - http://www.scopus.com/inward/record.url?scp=85078622953&partnerID=8YFLogxK

U2 - 10.1007/s00401-019-02107-8

DO - 10.1007/s00401-019-02107-8

M3 - Comment/Letter to the editor

C2 - 31955222

AN - SCOPUS:85078622953

SN - 0001-6322

VL - 139

SP - 959

EP - 962

JO - Acta Neuropathologica

JF - Acta Neuropathologica

IS - 5

ER -

van der Lee SJ, van den Akker E, Stringa N, Hulsman M , Tesi N, Alexopoulos P et al. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (vol 138, pg 237, 2019): A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8). Acta Neuropathologica. 2020;139(5):959-962. doi: 10.1007/s00401-019-02107-8

Abstract

Access to Document

Other files and links

Fingerprint

Cite this